观点:拯救脓毒症运动指南2021执行摘要推荐的科学依据薄弱
本文为观点文章,针对拯救脓毒症运动指南2021执行摘要首次推荐脓毒症休克时经外周置入静脉导管(PiVC)启动血管加压药输注最长6小时这一推荐,讨论其科学依据。作者围绕经外周血管导管输注血管加压药的安全性及可接受持续时间两方面,指出该推荐的科学依据薄弱。文章未报告原始研究数据、系统评价或新的临床结局。
要点
- 拯救脓毒症运动指南2021执行摘要首次推荐:脓毒症休克时经外周置入静脉导管(PiVC)启动血管加压药输注,最长6小时。
- 作者认为该推荐关于经外周血管导管输注血管加压药的安全性依据薄弱。
- 作者认为该推荐关于经外周血管导管输注血管加压药可接受持续时间的依据薄弱。
证据类型、等级与局限
- 证据类型:观点文章。
- 局限:原文未报告局限性。
指南或共识出处
- Nath SS, Nachimuthu N. Viewpoint: Weak Scientific Basis for the Recommendation of Executive Summary of Surviving Sepsis Campaign Guidelines 2021. Indian J Crit Care Med 2022;26(8):898-899.
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「研究设计与关键结果」「对床旁实践的改变」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: The Executive summary of Sepsis 2021 was published recently, which for the first time, recommended that in septic shock, the vasopressor infusion should be commenced through a peripherally inserted venous catheter (PiVC) for up to 6 hours. We discuss the scientific basis for such a recommendation regarding the safety of vasopressor infusion through a peripherally inserted vascular catheter or the accepted duration.
HOW TO CITE THIS ARTICLE: Nath SS, Nachimuthu N. Viewpoint: Weak Scientific Basis for the Recommendation of Executive Summary of Surviving Sepsis Campaign Guidelines 2021. Indian J Crit Care Med 2022;26(8):898-899.
参考来源
- Nath SS, Nachimuthu N. Viewpoint: Weak Scientific Basis for the Recommendation of Executive Summary of Surviving Sepsis Campaign Guidelines 2021. Indian J Crit Care Med. 2022. PMID: 36042756. doi:10.5005/jp-journals-10071-24277
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。